• Healthcare

    In the Healthcare Services segment, attractive investment opportunities are driven by capacity expansion, consolidation amongst service providers, and value creation through service improvement in what continues to be a fragmented and inefficient market.

     

    In the Pharma and Medtech segments, we seek to identify companies that stand to benefit from trends towards enhanced consumer choice, improved information available to patients and prevention over treatment.

  • Meet the team

    Frédéric Stévenin

    Stefano Drago

  • Atos Medical

    Atos Medical is a fast-growing medical device company with an undisputed global leadership in laryngectomy products.

    Healthcare
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition SEK 7,660 million
    • Headquarters Sweden
    • www.atosmedical.com
  • Ethypharm

    Ethypharm is a specialty pharmaceutical company with leading positions in pain and addiction treatements.

    Healthcare
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition €725m
    • Headquarters France
    • www.ethypharm.com
  • DomusVi

    DomusVi is the third biggest private player in the nursing home sector in France and the leader in Spain, operating c. 200 nursing homes.

    Healthcare
    • Investment date September 2014
    • Fund PAI Europe VI
    • Value at acquisition €639m
    • Headquarters France
    • www.domusvi.com
  • Cerba Healthcare

    Cerba is a leading operator of clinical pathology laboratories in Europe with a number one position in France and strong market positions in Belgium, Luxembourg and Africa.

    Healthcare
    • Investment date July 2010
    • Fund PAI Europe V
    • Value at acquisition €551m
    • Headquarters France
    • www.cerbahealthcare.com
  • Ceva

    Animal health products.

    Healthcare
    • Exit date September 2003
    • Investment date October 1999
    • Fund PAI LBO Fund
    • Value at acquisition €71m
    • Value at exit €202m
    • Headquarters France
    • www.ceva.com/en/
  • Ipsen

    Pharmaceutical laboratory.

    Healthcare
    • Exit date June 2006
    • Investment date December 1998
    • Fund PAI LBO Fund
    • Value at acquisition €1,285m
    • Value at exit €2,125m
    • Headquarters France
    • www.ipsen.com
Back to top